What Matters Most in OI Treatment?

OIF Community Survey on Drug Treatment Priorities
The OIF is asking adults with OI and parents/caregivers of children with OI to share what matters most to them when thinking about OI drug treatments. We want to understand how OI affects you or your child and which aspects of health and daily life you would most like treatments to improve.
Your responses will help the OIF better understand the OI community’s treatment priorities and may be used to help inform researchers, clinicians, and others involved in developing and studying current and future OI drug treatments. You do not need to have taken part in a clinical trial or used an OI drug treatment to complete this survey.
Responses from all countries are welcome. If you are an adult with OI and also have a child with OI, you are welcome to complete the survey twice—once for yourself and once on behalf of your child.
1.Are you completing this survey:(Required.)
2.In what country do you/your child live in?(Required.)
3.Age of the person with OI:(Required.)
4.What is the sex of the person with OI?(Required.)
5.Overall, how would you describe the severity of your/your child’s OI?(Required.)
6.OI type, if known:(Required.)
7.How do you/your child usually get around at home? (Select all that apply)(Required.)
8.How do you/your child usually get around in the community? (Select all that apply)(Required.)
9.What are the most important things you would want a new OI drug treatment to do? (Select up to 3)(Required.)
10.When thinking about getting around and doing everyday activities, which improvement would be most important to you/your child?(Required.)
11.When thinking about a new OI drug treatment, how important is reducing ongoing pain compared with reducing fractures?(Required.)
12.If you/your child experience fatigue, which problem would you most want a new OI drug treatment to help with?(Required.)
13.How would you describe the frequency of pain you or your child have experienced in the past 4 weeks?(Required.)
14.If a drug greatly reduced your/your child’s pain but did NOT reduce the number of fractures, would you still consider the treatment valuable?(Required.)
15.If a drug greatly increased your/your child’s mobility, stamina, or ability to be active and participate in daily life, but did NOT reduce the number of fractures, would you still consider the treatment valuable?(Required.)
16.Is there anything else you would like us to know about what would make a new OI drug treatment successful for you/your child?